Filament Health Statistics
Total Valuation
Filament Health has a market cap or net worth of CAD 7.17 million. The enterprise value is 7.04 million.
Market Cap | 7.17M |
Enterprise Value | 7.04M |
Important Dates
The last earnings date was Monday, March 31, 2025.
Earnings Date | Mar 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +26.48% |
Shares Change (QoQ) | +2.16% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 92.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 5.57 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.42 |
EV / Sales | 11.71 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.01 |
Financial Position
The company has a current ratio of 0.44, with a Debt / Equity ratio of 0.15.
Current Ratio | 0.44 |
Quick Ratio | 0.43 |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | -0.11 |
Interest Coverage | -15.78 |
Financial Efficiency
Return on equity (ROE) is -234.51% and return on invested capital (ROIC) is -79.02%.
Return on Equity (ROE) | -234.51% |
Return on Assets (ROA) | -52.40% |
Return on Invested Capital (ROIC) | -79.02% |
Return on Capital Employed (ROCE) | -202.13% |
Revenue Per Employee | 47,437 |
Profits Per Employee | -382,329 |
Employee Count | 13 |
Asset Turnover | 0.14 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 1.14, so Filament Health's price volatility has been higher than the market average.
Beta (5Y) | 1.14 |
52-Week Price Change | -66.67% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 26.42 |
Average Volume (20 Days) | 15,931 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Filament Health had revenue of CAD 616,678 and -4.97 million in losses. Loss per share was -0.02.
Revenue | 616,678 |
Gross Profit | 616,678 |
Operating Income | -3.77M |
Pretax Income | -4.97M |
Net Income | -4.97M |
EBITDA | -3.55M |
EBIT | -3.77M |
Loss Per Share | -0.02 |
Balance Sheet
The company has 391,237 in cash and 264,502 in debt, giving a net cash position of 126,735.
Cash & Cash Equivalents | 391,237 |
Total Debt | 264,502 |
Net Cash | 126,735 |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.75M |
Book Value Per Share | 0.01 |
Working Capital | -859,508 |
Cash Flow
In the last 12 months, operating cash flow was -2.29 million and capital expenditures -50,478, giving a free cash flow of -2.34 million.
Operating Cash Flow | -2.29M |
Capital Expenditures | -50,478 |
Free Cash Flow | -2.34M |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -610.99% |
Pretax Margin | -805.98% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Filament Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -26.48% |
Shareholder Yield | -26.48% |
Earnings Yield | -69.34% |
FCF Yield | -32.64% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |